News
-
-
-
COMMUNIQUÉ DE PRESSE
Next Gen Diagnostics Announces Agreement to Develop Sequence-Based Susceptibility Determination of Cefiderocol
Next Gen Diagnostics partners with Shionogi to develop whole genome sequence-based models for cefiderocol susceptibility in Gram-negative bacteria, enhancing antibiotic testing -
-
-
COMMUNIQUÉ DE PRESSE
Dr. Alexander Sundermann Joins Next Gen Diagnostics as Its Director of Infection Prevention Services
Next Gen Diagnostics appoints Dr. Alexander Sundermann of University of Pittsburgh School of Public Health as Director of Infection Prevention Services. Dr. Sundermann is a key figure in prospective sequencing for infection detection -
-
-
COMMUNIQUÉ DE PRESSE
Next Gen Diagnostics Announces Opening of a US Sequencing and Bioinformatics Laboratory in Cambridge, Massachusetts
Next Gen Diagnostics announces the opening of its first US laboratory in Cambridge, MA, offering low-cost bacterial sequencing and bioinformatics services. The company leverages advanced technologies for high throughput and cost-effective analysis -
